▶ 調査レポート

カンナビノイドの世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Cannabinoids Market (Product Type: Cannabinoids, Tetrahydrocannabinol, Cannabinol, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。カンナビノイドの世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測 / Cannabinoids Market (Product Type: Cannabinoids, Tetrahydrocannabinol, Cannabinol, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2207A097資料のイメージです。• レポートコード:MRC2207A097
• 出版社/出版日:Transparency Market Research / 2022年5月
• レポート形態:英文、PDF、190ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥764,940 (USD5,795)▷ お問い合わせ
  Multi User¥1,160,940 (USD8,795)▷ お問い合わせ
  Corporate License¥1,556,940 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
トランスペアレンシー・マーケット・リサーチ社の本調査レポートでは、世界のカンナビノイド市場について総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別(カンナビノイド、テトラヒドロカンナビノール、カンナビノール、その他)分析、流通チャネル別分析、用途別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの内容をまとめております。なお、本書に掲載されている企業情報にはMylan N.V. (Viatris Inc.)、Alkem Labs、GW Pharmaceuticals plc、Tilray, Inc.、Aurora Cannabis, Inc.、Canopy Growth Corporation、The Cronos Groupなどが含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界のカンナビノイド市場規模:製品別(カンナビノイド、テトラヒドロカンナビノール、カンナビノール、その他)
・世界のカンナビノイド市場規模:流通チャネル別
・世界のカンナビノイド市場規模:用途別
・世界のカンナビノイド市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Cannabinoids Market – Scope of Report

TMR’s report on the global cannabinoids market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global cannabinoids market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cannabinoids market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cannabinoids market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cannabinoids market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global cannabinoids market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cannabinoids market.

The report delves into the competitive landscape of the global cannabinoids market. Key players operating in the global cannabinoids market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cannabinoids market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market cannabinoids.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cannabinoids Market
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Cannabinoids Market Analysis and Forecast, 2017–2031
4.3.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Porter’s Five Forces Analysis
5.2. PESTLE Analysis
5.3. Cannabis Genetics: Overview & Analysis
5.4. Regulatory Scenario, by Region/Globally
5.5. Pricing Analysis
5.6. List of key Competitors
5.7. COVID-19 Impact Analysis
5.8. Key Industry Development
6. Global Cannabinoids Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Cannabidiol
6.3.2. Tetrahydrocannabinol
6.3.3. Cannabinol
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Cannabinoids Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Distribution Channel, 2017–2031
7.3.1. Hospitals Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Stores
7.4. Market Attractiveness Analysis, by Distribution Channel
8. Global Cannabinoids Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Medicinal Use
8.3.1.1. Chronic Pain
8.3.1.2. Neurological Disorders Management
8.3.1.3. Oncology
8.3.1.4. Others
8.3.2. Non-medical Use
8.4. Market Attractiveness Analysis, by Application
9. Global Cannabinoids Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Cannabinoids Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Cannabidiol
10.2.2. Tetrahydrocannabinol
10.2.3. Cannabinol
10.2.4. Others
10.3. Market Value Forecast, by Distribution Channel, 2017–2031
10.3.1. Hospitals Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Stores
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Medicinal Use
10.4.1.1. Chronic Pain
10.4.1.2. Neurological Disorders Management
10.4.1.3. Oncology
10.4.1.4. Others
10.4.2. Non-medical Use
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Distribution Channel
10.6.3. By Application
10.6.4. By Country
11. Europe Cannabinoids Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Cannabidiol
11.2.2. Tetrahydrocannabinol
11.2.3. Cannabinol
11.2.4. Others
11.3. Market Value Forecast, by Distribution Channel, 2017–2031
11.3.1. Hospitals Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Stores
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Medicinal Use
11.4.1.1. Chronic Pain
11.4.1.2. Neurological Disorders Management
11.4.1.3. Oncology
11.4.1.4. Others
11.4.2. Non-medical Use
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Distribution Channel
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Cannabinoids Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Cannabidiol
12.2.2. Tetrahydrocannabinol
12.2.3. Cannabinol
12.2.4. Others
12.3. Market Value Forecast, by Distribution Channel, 2017–2031
12.3.1. Hospitals Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Stores
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Medicinal Use
12.4.1.1. Chronic Pain
12.4.1.2. Neurological Disorders Management
12.4.1.3. Oncology
12.4.1.4. Others
12.4.2. Non-medical Use
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Japan
12.5.2. India
12.5.3. Australia & New Zealand
12.5.4. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Distribution Channel
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Cannabinoids Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Cannabidiol
13.2.2. Tetrahydrocannabinol
13.2.3. Cannabinol
13.2.4. Others
13.3. Market Value Forecast, by Distribution Channel, 2017–2031
13.3.1. Hospitals Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Stores
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Medicinal Use
13.4.1.1. Chronic Pain
13.4.1.2. Neurological Disorders Management
13.4.1.3. Oncology
13.4.1.4. Others
13.4.2. Non-medical Use
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Distribution Channel
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Cannabinoids Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Cannabidiol
14.2.2. Tetrahydrocannabinol
14.2.3. Cannabinol
14.2.4. Others
14.3. Market Value Forecast, by Distribution Channel, 2017–2031
14.3.1. Hospitals Pharmacies
14.3.2. Retail Pharmacies
14.3.3. Online Stores
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Medicinal Use
14.4.1.1. Chronic Pain
14.4.1.2. Neurological Disorders Management
14.4.1.3. Oncology
14.4.1.4. Others
14.4.2. Non-medical Use
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. South Africa
14.5.2. Israel
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Distribution Channel
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Mylan N.V. (Viatris Inc.)
15.2.1.1. Company Overview
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Business Strategies
15.2.1.5. Recent Developments
15.2.2. Alkem Labs
15.2.2.1. Company Overview
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Business Strategies
15.2.2.5. Recent Developments
15.2.3. GW Pharmaceuticals plc
15.2.3.1. Company Overview
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Business Strategies
15.2.3.5. Recent Developments
15.2.4. Tilray, Inc.
15.2.4.1. Company Overview
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Business Strategies
15.2.4.5. Recent Developments
15.2.5. Aurora Cannabis, Inc.
15.2.5.1. Company Overview
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Business Strategies
15.2.5.5. Recent Developments
15.2.6. Canopy Growth Corporation
15.2.6.1. Company Overview
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Business Strategies
15.2.6.5. Recent Developments
15.2.7. The Cronos Group
15.2.7.1. Company Overview
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Business Strategies
15.2.7.5. Recent Developments

List of Tables
Table 01: Global Cannabinoids Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Cannabinoids Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Cannabinoids Market Value (US$ Mn) Forecast, by Medicinal Use, 2017–2031
Table 04: Global Cannabinoids Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 05: Global Cannabinoids Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Cannabinoids Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Cannabinoids Market Revenue (US$ Mn) Forecast, by Product Type, 2017–2031
Table 08: North America Cannabinoids Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
Table 09: North America Cannabinoids Market Revenue (US$ Mn) Forecast, by Medicinal Use, 2017–2031
Table 10: North America Cannabinoids Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 11: Europe Cannabinoids Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Cannabinoids Market Revenue (US$ Mn) Forecast, by Product Type, 2017–2031
Table 13: Europe Cannabinoids Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
Table 14: Europe Cannabinoids Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 15: Asia Pacific Cannabinoids Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Asia Pacific Cannabinoids Market Revenue (US$ Mn) Forecast, by Product Type, 2017–2031
Table 17: Asia Pacific Cannabinoids Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
Table 18: Asia Pacific Cannabinoids Market Revenue (US$ Mn) Forecast, by Application (Medicinal Use), 2017–2031
Table 19: Asia Pacific Cannabinoids Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 20: Latin America Cannabinoids Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Latin America Cannabinoids Market Revenue (US$ Mn) Forecast, by Product Type, 2017–2031
Table 22: Latin America Cannabinoids Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Latin America Cannabinoids Market Revenue (US$ Mn) Forecast, by Application (Medicinal Use), 2017–2031
Table 24: Latin America Cannabinoids Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 25: Middle East & Africa Cannabinoids Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Middle East & Africa Cannabinoids Market Revenue (US$ Mn) Forecast, by Product Type, 2017–2031
Table 27: Middle East & Africa Cannabinoids Market Revenue (US$ Mn) Forecast, by Application, 2017–2031
Table 28: Middle East & Africa Cannabinoids Market Revenue (US$ Mn) Forecast, by Application (Medicinal Use), 2017–2031
Table 29: Middle East & Africa Cannabinoids Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2031